Back to today’s briefing

Story perspectives

New Gut Analysis Tool Predicts 84% Mortality Risk

6/18/2025

40 6

Summary

Story summary

A groundbreaking metabolic dysbiosis score (MDS) developed by researchers at the University of Chicago, led by Alexander de Porto, reveals a striking 84% accuracy in predicting mortality risk in critically ill patients through fecal analysis. While promising, this innovative tool needs further validation, paving the way for future studies to explore targeted gut metabolite therapies.

1 of 1

Story summary

A groundbreaking metabolic dysbiosis score (MDS) developed by researchers at the University of Chicago, led by Alexander de Porto, reveals a striking 84% accuracy in predicting mortality risk in critically ill patients through fecal analysis. While promising, this innovative tool needs further validation, paving the way for future studies to explore targeted gut metabolite therapies.